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Abstract
Background: Lassa fever is a viral hemorrhagic fever endemic in West Africa. The reservoir host of the virus is a
multimammate rat, Mastomys natalensis. Prevalence estimates of Lassa virus antibodies in humans vary greatly between
studies, and the main modes of transmission of the virus from rodents to humans remain unclear. We aimed to (i) estimate
the prevalence of Lassa virus–specific IgG antibodies (LV IgG) in the human population of a rural area of Guinea, and (ii)
identify risk factors for positive LV IgG.
Methods and Findings: A population-based cross-sectional study design was used. In April 2000, all individuals one year of
age and older living in three prefectures located in the tropical secondary forest area of Guinea (Gueckedou, Lola and
Yomou) were sampled using two-stage cluster sampling. For each individual identified by the sampling procedure and who
agreed to participate, a standardized questionnaire was completed to collect data on personal exposure to potential risk
factors for Lassa fever (mainly contact with rodents), and a blood sample was tested for LV IgG. A multiple logistic regression
model was used to determine risk factors for positive LV IgG. A total of 1424 subjects were interviewed and 977 sera were
tested. Prevalence of positive LV Ig was of 12.9% [10.8%–15.0%] and 10.0% [8.1%–11.9%] in rural and urban areas,
respectively. Two risk factors of positive LV IgG were identified: to have, in the past twelve months, undergone an injection
(odds ratio [OR]=1.8 [1.1–3.1]), or lived with someone displaying a haemorrhage (OR=1.7 [1.1–2.9]). No factors related to
contacts with rats and/or mice remained statistically significant in the multivariate analysis.
Conclusions: Our study underlines the potential importance of person-to-person transmission of Lassa fever, via close
contact in the same household or nosocomial exposure.
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Introduction
Lassa fever (LF) is a viral haemorrhagic fever endemic in West
Africa, caused by a single stranded RNA virus, member of the
family Arenaviridae [1]. The disease is estimated to affect 2 million
persons per year and cause 5,000 to 10,000 deaths [2]. It is
expected to be largely under diagnosed as early symptoms are
similar to those of other diseases such as malaria, leptospirosis or
typhoid fever in endemic areas [3], and because many Lassa
infections result in mild disease and never develop more specific
symptoms associated with severe disease [2]. An adapted case
definition for a suspected case has been defined, based on the
observation of a large number of cases at Kenema Government
Hospital in Sierra Leone (box S1) [4].
High rates of seroprevalence of Lassa fever have been reported
in West Africa particularly in Guinea, Sierra Leone, Liberia and in
Nigeria. In Cote d’Ivoire, Ghana, Togo and Benin, seroprevalence
is lower, but isolated cases show evidence of viral circulation [5–7].
The reservoir host is the multimammate rat, Mastomys natalensis,
first found infected in Sierra Leone and in Nigeria in 1972 [8,9]
and more recently in Guinea [10]. In northern Guinea, these
commensal rodents aggregate in houses during the dry season, and
disperse into gardens and the surrounding fields in the rainy
season, foraging in cultivated areas before harvesting [11]. Several
modes of virus transmission are suspected. Rodent-to-human
infection could occur through the inhalation of aerosols or by
direct contact with infected rodent excreta [12,13]. Rodent
consumption was also evoked as a possible risk behaviour
[14,15]. Person-to-person transmission occurs via direct contact
with infected blood, urine, or pharyngeal secretions and is
responsible for numerous outbreaks [16–22]. Most reported
outbreaks have occurred in healthcare facilities in endemic areas,
strongly suggesting a nosocomial transmission of the virus,
probably through inadequate implementation of universal pre-
cautions, including reuse of syringes [23]. Nevertheless, Lassa
serosurveys carried out in rural areas suggest that many villagers
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communities studied between 1978 and 1983 had Lassa IgG
seroprevalence ranging from 10% to 52% [13], and others in
forest Guinea showed seroprevalence between 19% and 55% in
1991–1992 [24]. Sporadic cases are also documented among
visitors to the region [6,7,25].
With the aim of identifying risk factors for transmission of Lassa
virus, we performed a cross-sectional study in communities of the
forest region of Guinea. In the same region, the team led by J. ter
Meulen previously identified consumption of rodent meat as a
potentially important risk factor for positive Lassa fever serology
[14]. Therefore, we paid particular attention to exposures related
to wild fauna, with the aim of further detailing which contacts with
rodents (through collection, manipulation or consumption, etc.)
would be at higher risk. Clinical signs during the twelve months
before collection were also investigated to explore the association
between symptoms compatible with Lassa fever and a positive
Lassa serology.
In 1997, a research project on viral hemorrhagic fevers in the
Mano River countries (Guinea, Liberia and Sierra Leone) and
Ivory Coast was initiated by Ministries of Health, the University of
Conakry, Epicentre, the Bernhard Nocht Institute in Hambourg
(Germany), and the Institute Pasteur in Lyon (France).
Methods
Setting
We conducted a cross-sectional seroprevalence survey in three
prefectures of Guinea, Gue ´ckedou, Lola and Yomou, all located in
the tropical secondary forest area of the country in April 2000
(figure 1). Two-stage cluster sampling was used for selection of
villages/towns and households, following the standard WHO EPI
survey method [26]. In the first step, villages or towns were
selected with probability proportional to population size; secondly
households; then finally one individual within each household.
The list of towns and villages and population sizes for the sampling
frame was provided by the regional health authorities, based on
the most recent census (updated in the year 2000). Households
Figure 1. Location of 30 villages in Lassa fever serosurvey, Guinea, 2000.
doi:10.1371/journal.pntd.0000548.g001
Author Summary
Lassa fever is a viral haemorrhagic fever endemic in West
Africa, mainly transmitted to humans by multimammate
rats. Several modes of virus transmission are suspected:
aerosolisation of the virus, contact with infected rodent
excreta, and consumption of rodent meat. Person-to-
person transmission also occurs via contact with body
fluids of infected persons (blood, urine) and is responsible
for numerous outbreaks, mostly in healthcare facilities. Our
objective was to precisely describe risk factors for Lassa
fever in both rural and urban communities of forest
Guinea. For each participant, a standardized questionnaire
was completed and a blood sample tested for Lassa virus
antibodies. A total of 1424 subjects were interviewed and
977 blood samples tested. The prevalence of Lassa virus
antibodies was estimated at 12.9% and 10.0% in rural and
urban areas, respectively. The two risk factors were: to
have, in the past twelve months, undergone an injection,
or lived with someone displaying a haemorrhage. Contrary
to our expectation, no factors related to contact with
rodents were identified. It is still probable that transmis-
sion occurs via indirect contact between rodents and
humans in households, but our results highlight the
importance of person-to-person transmission via close
contact and nosocomial exposure.
Lassa Fever in Guinea
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and beds for at least the previous 6 months. In each selected
village, the investigators started at a central point, randomly
selected a direction from that point and chose one dwelling at
random among those along the line from the centre to the edge of
the village. Starting from this household, the next nearest
household along the line was visited in turn until the size of the
cluster was reached. Within each household sampled, one
individual was randomly selected among individuals aged 1 year
and older who had been living in the selected prefectures for more
than 6 months.
Data collection
Authorization for the survey had been obtained from the
Guinea Ministry of Health and the University of Conakry. Both
institutions approved oral consent prior to the initiation of the
study, considering that the target population was predominantly
illiterate. The purpose of the survey was explained to district
administrative authorities, and then to village leaders and
communities during public meetings a few days before investiga-
tion, and their agreement was requested. In each household, the
investigators explained the survey objectives to the head of the
household. Individuals identified by the sampling procedure were
then invited to participate and informed oral consent was
documented in the case report form for each participant. Consent
was obtained by the investigators (nurses and/or physicians) in
presence of the local guide, in order to improve adherence to the
survey methodology and ensure appropriate translation of the
questionnaire. Parents provided consent for children. The survey
team consisted of six persons, working in pairs simultaneously in
each prefecture and speaking the local dialect. Members of the
survey teams underwent two days of training to familiarize
themselves with the questionnaire and the sampling method.
The questionnaire was administered during an individual
interview, including demographic data, questions on knowledge
and beliefs on viral haemorrhagic fevers, information on personal
exposure to potential risk factors, and clinical signs in the past
twelve months. Specific questions concerned personal habits of
collecting rodents, cutting up or eating dead rodents, professional
occupation, contacts with other animals (monkeys, bats), history of
surgical intervention or injection in the past twelve months,
contact with a person displaying jaundice, haemorrhage, or
someone who died of unknown causes. Our results derive from a
study with Yellow fever as primary target disease. The project was
later extended towards Ebola and Lassa fever, so that the
questionnaire includes the exposure to animals which are not
thought to harbour Lassa virus. Participants were asked about
their current habits concerning contacts with rodents, and about
injections and contact with people displaying hemorrhage etc.
within the past twelve months.
After granting oral consent, participants provided a blood
sample for Lassa virus–specific Immunoglobulin G (LV IgG)
testing. Trained nurses collected all blood samples in accordance
with a standardized procedure.
Laboratory analysis
Specimens were analysed in the laboratory of the University
hospital of Conakry. LV IgG were detected by indirect
immunofluorescence assay using acetone-fixed Vero cells infected
with Lassa virus strain Josiah according to the method described in
ter Meulen et al. [14]. Immunofluorescence slides for Lassa fever
serology were provided by the Bernhard Nocht Institute of
Hamburg (Germany).
Statistical analysis
Results are expressed as the median [min-max] for continuous
variables and N (%) for categorical variables. The effects of
continuous covariates were studied using Student’s t-test or the
Wilcoxon test when relevant. Fisher’s exact tests were used for
categorical variables.
A multiple logistic regression was performed to determine risk
factors for positive LV IgG in our population. In the question-
naire, exposure to close contacts with rodents, bats, and monkeys
was measured by a four-level ordinal variable (coded as ‘never’,
‘rarely’, ‘occasionally’ and ‘often’ exposed). This variable was
transformed into a two-level categorical variable coded as: ‘never
exposed’ versus ‘rarely, occasionally or often exposed’. In the
region of ‘Guine ´e forestie `re’, we observed that the word ‘mouse’
usually refers to the domestic mouse or the multimammate mouse
(Mastomys), contrary to the word ‘rat’ used to designate the black
rat (Rattus rattus) or the giant rat (Cricetomys gambianus); the latter
have never been reported as a reservoir for Lassa virus. Since it
was impossible to confidently estimate the number of people who
call mastomys a rat, we analysed exposure to rodents in two
different ways: first by studying mice and rats separately, then by
combining them into one exposure variable. All variables were
included in the unadjusted analysis. We included in the
multivariable model all variables achieving a P-value ,0.25 in
the unadjusted analysis, and all established risk factors for Lassa
fever (mainly contacts with rodents), according to the published
literature. The clustered structure of the data was taken into
account in all tests by introducing a frailty term in the logistical
regression models. We also adjusted for the prefecture term in all
models. A backward stepwise variable selection procedure was
applied to remove factors with P-value .0.05 (z-statistic).
Epi-Info was used to perform two-stage cluster sampling
(Centers for Disease Control and Prevention [http://www.cdc.
gov/epiinfo/]). Statistical analyses were carried out using R 2.4.0
statistical package (R Development Core Team; R Foundation for
Statistical Computing, Vienna, Austria [http://www.R-project.
org]).
Results
Between 10 and 22 April 2000, in the 30 villages and towns
selected, 1424 participants were interviewed and 1400 provided a
blood specimen. Twenty-four participants did not give their
consent for serological testing. Clusters were located in the
prefectures of Gueckedou, Lola and Yomou (respectively 9, 12 and
9 clusters). Thirteen of the 30 clusters were considered to be
‘urban’ by the field investigators (defined as population size above
3,000 and easy road access).
Over the 1400 sera collected, 1347 were tested for Yellow Fever
and only 977 for Lassa fever. Lassa fever immunofluorescence
could not be conducted on all sera since the laboratory in Conakry
did not have a sufficient supply of immunofluorescence slides to
complete the Lassa serology tests. It was noted that sera from rural
areas were less likely to be tested (proportions of non-tested sera
were 36% and 26% respectively in rural and urban areas,
p,10
24). No other differences (i.e. on age, gender) were observed
between tested and non tested sera. Socio-demographic charac-
teristics of all individuals included in the study are summarized in
Table 1.
The overall unadjusted prevalence of LV IgG was 11.5% (95%
CI=[9.5–13.5]), and 11.3% [9.3–13.3] when adjusting for the
variation in the proportion of samples tested between urban and
rural areas. Seroprevalence was 12.9% [10.8–15.0] and 10.0%
[8.1–11.9], in rural and urban clusters respectively. The
Lassa Fever in Guinea
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most affected age-classes were: under 10 and between 20 and 29
years of age, in both sexes but differences were not significant
(P=0.54 and 0.66 respectively for females and males, Pearson’s
chi-square test). Figures 3, 4 and 5 show the distribution of the
frequency of contacts with mice and/or rats according to age of
the respondent (see tables S1, S2 and S3 for detailed numeric
data). Only a small proportion of subjects reported collecting mice
and/or rats in their everyday life. This practice seems to increase
with age: no children under 10 years of age admitted collection of
dead rodents, compared to 18% among those aged 70 and above
(P,0.001, chi-squared test for trend). As shown in figure 4, a
history of cutting up mice and/or rats was rare among children,
and tended to increase with age (p,10
24, chi-squared test for
trend). Figure 5 shows that eating mice and/or rats was common
among persons included in the study, and comparable in all age
groups, 70–80% of persons reporting rare or occasional consump-
tion (figure S1 details data for each species).
Results of the univariate analysis of risk factors for positive LV
IgG are shown in table 2. Variables achieving a P-value ,0.25 in
the marginal analysis were those concerning the location of the
village (prefecture), type of residence (rural/urban), exposure to
animals (work in a slaughterhouse, animal bites or scratches in the
past twelve months), gathering of plants, use of traditional
medicine, personal history of medical injection, or contact with
someone displaying haemorrhage. Contacts with rodents (in
Figure 2. Prevalence of Lassa virus-specific IgG by age and sex,
Guinea, 2000 (N=975).
doi:10.1371/journal.pntd.0000548.g002
Figure 3. History of collecting rats and/or mice, Lassa fever
serosurvey, Guinea, 2000 (N=1404). Only a small proportion of
subjects declared habits of collecting dead rats and/or mice in their
everyday life. This practice seems to increase with age: for children
under 10 years of age, no subject declared rare or occasional collection
of rats and/or mice compared to 13% among those aged 70 and above.
doi:10.1371/journal.pntd.0000548.g003
Table 1. Demographic characteristics of participants, Lassa
fever serosurvey, Guinea, 2000.
N( % ) N
Median [IQR]
Women 792 (56) 1424
Age (years) 30 1421
[2–18–46–99]
District 1424
Gueckedou 453 (32)
Lola 514 (36)
Yomou 457 (32)
Occupation 1344
Housewife 564 (40)
Farmer 330 (23)
Apprentice/student 195 (14)
Dayworkers/tradesman 75 (5)
Shop owner 23 (2)
Teacher 12 (1)
Auxiliary midwife (‘‘matrone’’) 9 (1)
Healthworkers 5 (1)
No profession 94 (7)
Others 37 (3)
Religion 1397
Christian 584 (42)
Muslim 395 (28)
Animist 197 (14)
No religion 202 (15)
Other 19 (1)
Positive Lassa virus–specific
immunoglobulin G
112 (12) 977
Results are expressed as the median [min - 1st quartile - 3rd quartile - max] for
continuous variables and N (%) for categorical variables.
doi:10.1371/journal.pntd.0000548.t001
Lassa Fever in Guinea
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positive LV IgG.
Both multivariable analyses (first with each rodent indepen-
dently, and second with mice and rats taken together) gave the
same result: no variable concerning exposure to rodents was
significant in the final model. The two risk factors of positive LV Ig
were to have, in the past twelve months: (i) undergone an injection
(OR=1.8 [1.1–3.1]); and (ii) lived with someone displaying a
haemorrhage (OR=1.7 [1.1–2.9]). The test on the frailty term
was significant (p=0.002), suggesting a heterogeneous cluster
variation (design effect=3.9).
Table 3 describes the clinical signs declared by the participants
in the past twelve months. Signs that were significantly linked to
positive LV IgG were those implying bleeding (bleeding nose,
gums, bloody diarrhoea, or blood coming from the eyes) and
jaundice. Hearing loss was not associated with presence of LV
IgG; however, numbers of cases were small (respectively 19 and 3
in the LV IgG negative and positive groups). Other clinical signs,
such as cough, sore throat, vomiting, did not seem to be specific of
Lassa fever infection. It is important to note that 13% of
participants with positive LV IgG reported no clinical signs in
the past twelve months.
Discussion
Our study showed an adjusted overall prevalence of Lassa virus
antibodies of 11.3% [9.3–13.3] in the year 2000, which is lower
than previously published for the same region. In 1990–92,
Lukashevich et al. estimated the seroprevalence for Lassa to be
23.6% (738/3,126) [24]. Lassa fever is a disease of rural areas
influenced by the composition of the rodent population [10,11].
Houses in villages close to roads, railways, commercial areas or
with a higher human density harbour many domestic mice (Mus
musculus) and black rats (Rattus rattus), but fewer Mastomys [27]. In
suburban or peri-urban areas it is likely that the density of
Mastomys and thus the risk for humans to contract the virus are
lower. In our study, all villages of the region were eligible to be
included with a probability proportional to population size, so that
13 of the 30 clusters (representing 46% of the study population)
were located in urban areas (population size above 3,000 and easy
road access), while Lukashevitch et al. collected samples in villages
with 100–400 inhabitants only. This may explain why our
estimation of the Lassa seroprevalence is lower than the one
reported by Lukashevich et al. (32%, 447/1403 in Forest Guinea).
Ter Meulen et al, who like us used the EPI sampling scheme in
1993, found a seroprevalence of 14.0% (105/751) [14], which is
not very different from our result. Another possible explanation
would be a lower sensibility of the Indirect Fluorescent Antibody
test used in our study, compared to the technique used by
Lukashevich et al. (ELISA with recombinant nucleocapsid protein
antigen). And last, on the basis of data presented by Lukashevich et
al. in 4 selected villages of the sample, the age structure of the
population seems to differ from ours, with a much lower
representation of children aged 5–14.
Another finding is that the prevalence of LV IgG does not
appear to increase with age (figure 2), which was expected to be
observed among people living in an endemic area of virus activity.
This bimodal distribution is similar to those observed by Ter
Meulen et al. in the same area, possibly reflecting different
patterns of exposure, gathered from many localities with different
epidemiological schemes [14]. This could also indicate that
detectable Lassa virus IgG may not be long-lasting if
exposure does not continue, as described for other viral
hemorrhagic fevers [28].
In the multiple logistical regression model, two risk factors for
positive serology were identified: having recently had an injection
and having lived with someone displaying a haemorrhage. These
two risk factors underline the importance of person-to-person
Figure 4. History of cutting up rats and/or mice, Lassa fever
serosurvey, Guinea, 2000 (N=1405). Habits of cutting up rats and/
or mice were rare among children, and tended to increase with age to
be relatively constant between age classes in adults.
doi:10.1371/journal.pntd.0000548.g004
Figure 5. History of eating rats and/or mice, Lassa fever
serosurvey, Guinea, 2000 (N=1396). Habits of eating rats and/or
mice were common among persons included in the study, and
comparable in all age groups, 70–80% of persons declaring rare or
occasional consumption.
doi:10.1371/journal.pntd.0000548.g005
Lassa Fever in Guinea
www.plosntds.org 5 November 2009 | Volume 3 | Issue 11 | e548Table 2. Univariate analysis of risk factors for presence of Lassa virus–specific IgG.
Risk Factor Lassa negative N=865 Lassa positive N=112 p N
Prefecture
{ 0.003 977
Gueckedou 322 (37) 25 (22)
Lola 289 (33) 52 (46)
Yomou 254 (29) 35 (31)
Age (years)
{ 30 30 0.73 975
[4–18–45–90] [5–20–41–89]
Women 477 (55) 67 (60) 0.36 977
Rural area
{ 431 (50) 64 (57) 0.16 977
Activities (rarely, occasionally or often exposed to…)
Collecting dead animals
{
Rats
{ 75 (9) 10 (9) 0.86 966
Mice
{ 78 (9) 11 (10) 0.73 966
Agoutis
{ 95 (11) 13 (12) 0.87 967
Squirrels
{ 76 (9) 13 (12) 0.38 967
Bats 81 (10) 13 (12) 0.49 967
Monkeys 74 (9) 13 (12) 0.29 959
Cutting up dead animals
{
Rats
{ 593 (69) 75 (68) 0.74 967
Mice
{ 570 (67) 72 (65) 0.74 966
Agoutis
{ 662 (77) 80 (72) 0.23 966
Squirrels
{ 674 (79) 81 (73) 0.18 966
Bats 541 (63) 73 (66) 0.68 964
Monkeys 598 (71) 73 (66) 0.32 959
Eating dead animals
{
Rats
{ 683 (80) 88 (80) 0.90 959
Mice
{ 665 (79) 82 (75) 0.33 956
Agoutis
{ 756 (89) 93 (85) 0.15 957
Squirrels
{ 685 (81) 84 (76) 0.25 957
Bats 648 (77) 84 (76) 0.81 949
Monkeys 686 (82) 84 (78) 0.29 944
Working in a slaughterhouse
{ 9 (1) 3 (3) 0.15 966
Caring of flock or herd 53 (6) 4 (4) 0.39 962
Gathering plants
{ 463 (54) 68 (61) 0.19 964
Taking traditional medicine
{ 652 (77) 96 (87) 0.01 962
Rats and/or mice in the household
{ 790 (93) 106 (96) 0.42 962
To have, in the last twelve months,
Been bitten or scratched by an animal
{ 89 (11) 17 (15) 0.15 962
Undergone a surgical intervention 18 (2) 2 (2) 1 971
Had an injection
{ 546 (64) 87 (78) 0.004 967
Undergone a scarification 133 (16) 20 (18) 0.58 951
Lived in the same household as someone displaying jaundice 183 (24) 27 (27) 0.46 867
Lived in the same household as someone displaying hemorrhage
{* 165 (21) 31 (32) 0.03 871
Lived in the same household as someone whodied of unknown causes 80 (10) 9 (9) 0.86 890
Participated in funeral rituals 109 (13) 16 (14) 0.65 960
Results are expressed as the median [min-max] for continuous variables and N (%) for categorical variables.
{Included in the multivariable model (suspected risk factors and/or p,0.25).
*Defined as: bleeding nose, bleeding gums, bloody diarrhea or blood coming from the eyes.
doi:10.1371/journal.pntd.0000548.t002
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that collection, manipulation or consumption of rodents were
significant risk factors for positive LV IgG. Direct contact with
rodents has always been suspected as a route of transmission to
humans, based on several arguments: (1) the reservoir of the virus
is a ubiquitous peridomestic rodent Mastomys natalensis; (2) rodents
are infected in-utero and remain infective throughout life,
excreting between 1000 and 10,000 infectious viral particles/mL
of urine [2]; (3) there are geographical correlations between
prevalence of LF in humans and rodents’ infestation. Forest areas
have a higher Lassa seroprevalence in humans and a higher
occurrence of Mastomys [27] and houses with a higher proportion
of infected rodents are associated with higher infection rates in
human populations [2]. Consumption of rodents has been
suspected as a possible route of disease transmission, but to our
knowledge, this link has never been formally demonstrated. In a
population-based study, Ter Meulen et al.have correlated possible
risk factors for rodent-to-human transmission of Lassa virus with
markers of Lassa Fever in two different regions of the Republic of
Guinea. In one selected area, they found that 14.6% of rodent
consumers had Lassa virus antibodies versus 7.4% of non-
consumers, but the association failed to reach the conventional
5% significance threshold (P=0.10) [14]. Despite in-depth
questioning, habits of collecting, cutting up, or eating rodents
was not associated with higher prevalence of LV Ig G, after
adjusting for other factors. In our study, 46% of the study
population lived in urban or peri-urban areas, and this modifies
exposure to rodents. Misclassification due to the inclusion of
people with contacts to agoutis, squirrels and rats in the exposed
group may also explain why contact with rodents was not
identified as risk factor for Lassa seropositivity. However, the
hypothesis of transmission through rodent consumption is
weakened by the observation that in rural areas, rodents are
usually hunted far from houses in remote plantations (pers. obs.)
whereas M. natalensis, the only reservoir of the virus, is mainly
found around human dwellings [27].
Our study reinforces the importance of person-to-person
transmission, within the same household or through nosocomial
exposure, via contact with body fluids of ill persons. It has long
been known that Lassa virus may persist at low levels in the urine
of humans for up to two months after infection (without circulation
in the blood) [29]. Even if there are no studies on the presence of
Lassa virus in semen, sexual transmission during convalescence
could be considered to be a possibility, like for other hemorrhagic
fevers in Africa such as Ebola [30]. There is also anecdotal
evidence suggesting venereal rodent-to-rodent transmission of the
etiologic arenaviruses of three South American hemorrhagic fevers
(Argentine, Bolivian and Venezuelan), which also emphasizes the
possibility of sexual transmission of Lassa virus [31].
Our data on Lassa fever does not allow us to explore this
hypothesis, since we have no information on the serostatus of the
partners of the participants, and this could be an interesting topic
for further research.
Several limitations can be noted. First, our results may have
been affected by a recall bias over the 12 months recall period.
However, since the results of LV Ig were unknown at the time of
interview, such bias is unlikely to have affected the two groups
(positive/negative serology) differently. Second, over the 1400 sera
collected, only 977 were tested. Lack of reagents explains
discrepancy between total samples and tested samples. Sera from
rural areas were less likely to be tested (proportion of non-tested
sera were 36% and 26% respectively in rural and urban areas,
p,10
24), also suggesting transportation problems. This over-
representation of habitants of urban areas may partly explain the
relatively low seroprevalence of LV IgG observed in our study.
Third, investigators may have had difficulties with the question-
naire, which was long and complex. Fourth, our sampling method
slightly differs from the EPI cluster sampling as described by
WHO. In our sample, only one eligible household member has
been selected instead of all eligible household members, probably
leading to an over-representation of individuals from small
households. For a disease like Lassa fever with human-to-human
transmission, it is likely that circulation of the virus is facilitated in
large households compared with small ones. Consequently, people
from small households are probably less likely to be infected,
which may have led to a moderate underestimation of the
prevalence. And finally, due the cross-sectional nature of the study
and long recall period, it is not possible to establish a temporal
relationship between risk exposure, clinical syndromes detected,
and serology results. For example, we cannot ascertain whether
participants with a history suggestive of Lassa fever had an
injection before or after onset of symptoms, that is, whether the
Table 3. History of symptoms among survey participants in the past twelve months by serologic status, Lassa fever serosurvey,
Guinea, 2000.
Clinical signs Lassa IgG negative N=865 Lassa IgG positive N=112 p N
History of fever associated with bleeding nose, gums, or blood coming from the eyes 223 (26) 41 (37) 0.02 966
History of fever followed within fifteen days by jaundice and bleeding 115 (14) 23 (21) 0.04 962
Cough 286 (33) 44 (39) 0.24 970
Sore throat 205 (24) 32 (29) 0.29 966
Abdominal pain 514 (60) 77 (69) 0.08 972
Vomiting 151 (18) 25 (23) 0.19 965
Bloody diarrhea 274 (32) 54 (48) 0.001 970
Jaundice 115 (13) 24 (21) 0.03 969
Hearing loss 19 (2) 3 (3) 0.73 968
Bleeding nose or gums 114 (13) 23 (21) 0.04 966
Dermatological lesions 292 (34) 34 (31) 0.52 964
No clinical symptoms 111 (13) 14 (13) 1 969
doi:10.1371/journal.pntd.0000548.t003
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With our data, it was also impossible to distinguish between people
who received an injection as a treatment of a possible Lassa fever,
to those who have been vaccinated or treated for malaria.
Despite these limitations, our findings are consistent with
previous observations of nosocomial transmission being an
important factor for transmission of VHF, and particularly Lassa
fever. Most documented Lassa Fever outbreaks have occurred in
health care facilities in endemic areas, strongly suggesting
inadequate implementation of universal precautions, e.g. reused
syringes [23]. Limited resources may lead to sharing and reuse of
disposable equipment, and increased risk of Lassa fever and other
viral hemorrhagic fever outbreaks such as Ebola [23,32].
Indications for parenteral treatment should be very restrictive in
order to avoid unnecessary injections. This is difficult because
people tend to believe that injections have superior therapeutic
value [23]. In our study, 897 persons (64%) reported having
received an injection in the past twelve months. This proportion is
very high for a healthy group, sampled from the general
population. No vaccination campaign had been conducted in
the region prior to the study. It is likely that these injections were
treatments against malaria, since in these rural regions, parenteral
quinine was the treatment of choice in 2000.
In conclusion, our results did not confirm consumption of
rodent meat to be an important risk factor for positive Lassa fever
serology. However, it is still probable that transmission from
rodents to humans occurs via indirect contact in households
through exposure to food or fomites soiled with rodent excretions
(faeces, urine etc) or to aerosolized virus. Close contacts with
infected humans (in the same household or via nosocomial
exposure) are also major routes of contamination. It is crucial to
reinforce standard hygiene precautions, particularly in health care
settings. Recent progress in development for a Lassa fever vaccine
[33] offers new opportunities for prevention of this deadly disease.
Evidence of nosocomial transmission of the disease suggests that
health workers may benefit from such vaccine in the future.
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